193 related articles for article (PubMed ID: 9150322)
1. Effects of two weeks of topical budesonide treatment on microvascular exudative responsiveness in healthy human nasal airways.
Greiff L; Andersson M; Svensson C; Akerlund A; Alkner U; Persson CG
Eur Respir J; 1997 Apr; 10(4):841-5. PubMed ID: 9150322
[TBL] [Abstract][Full Text] [Related]
2. Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways.
Greiff L; Andersson M; Svensson C; Persson CG
Clin Exp Allergy; 1997 Apr; 27(4):438-44. PubMed ID: 9146938
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids may not inhibit plasma exudation by direct vascular antipermeability effects in human airways.
Greiff L; Andersson M; Svensson C; Alkner U; Persson CG
Eur Respir J; 1994 Jun; 7(6):1120-4. PubMed ID: 7925882
[TBL] [Abstract][Full Text] [Related]
4. Steroid-sensitive indices of airway inflammation in children with seasonal allergic rhinitis.
Meyer P; Andersson M; Persson CG; Greiff L
Pediatr Allergy Immunol; 2003 Feb; 14(1):60-5. PubMed ID: 12603713
[TBL] [Abstract][Full Text] [Related]
5. Onset of action of a topical antihistamine as assessed by histamine challenge-induced plasma exudation responses.
Korsgren M; Andersson M; Larsson L; Aldén-Raboisson M; Greiff L
Ann Allergy Asthma Immunol; 2006 Feb; 96(2):345-8. PubMed ID: 16498858
[TBL] [Abstract][Full Text] [Related]
6. The "nasal pool"-device for challenge and lavage of the nasal mucosa in children: histamine-induced plasma exudation responses.
Greiff L; Meyer P; Svensson C; Persson CG; Andersson M
Pediatr Allergy Immunol; 1997 Aug; 8(3):137-42. PubMed ID: 9532254
[TBL] [Abstract][Full Text] [Related]
7. Topical nitroprusside may reduce histamine-induced plasma exudation in human nasal airways.
Greiff L; Andersson M; Svensson C; Nilsson M; Erjefält I; Erjefält JS; Persson CG
Allergy; 1995 Jul; 50(7):593-7. PubMed ID: 8588693
[TBL] [Abstract][Full Text] [Related]
8. Effects of benzalkonium chloride on innate immunity physiology of the human nasal mucosa in vivo.
Storaas T; Andersson M; Persson CG; Steinsvåg SK; Marko-Varga G; Greiff L
Laryngoscope; 2000 Sep; 110(9):1543-7. PubMed ID: 10983958
[TBL] [Abstract][Full Text] [Related]
9. Challenge-induced plasma exudation and mucinous secretion in human airways.
Greiff L; Andersson M; Coman WB; Lindberg H; Marko-Varga G; Wallwork B; Persson CG
Clin Physiol Funct Imaging; 2005 Jul; 25(4):241-5. PubMed ID: 15972027
[TBL] [Abstract][Full Text] [Related]
10. Exudative hyperresponsiveness of the airway microcirculation in seasonal allergic rhinitis.
Svensson C; Andersson M; Greiff L; Alkner U; Persson CG
Clin Exp Allergy; 1995 Oct; 25(10):942-50. PubMed ID: 8556565
[TBL] [Abstract][Full Text] [Related]
11. Effects of experimental changes in nasal airway pressure on mucosal output of plasma.
Berg S; Wollmer P; Andersson M; Persson CG; Greiff L
Clin Physiol Funct Imaging; 2003 May; 23(3):155-8. PubMed ID: 12752558
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid-induced attenuation of mucosal exudation of fibrinogen and bradykinins in seasonal allergic rhinitis.
Svensson C; Klementsson H; Andersson M; Pipkorn U; Alkner U; Persson CG
Allergy; 1994 Mar; 49(3):177-83. PubMed ID: 8198250
[TBL] [Abstract][Full Text] [Related]
13. Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways.
Svensson C; Pipkorn U; Alkner U; Baumgarten CR; Persson CG
Clin Exp Allergy; 1992 Mar; 22(3):411-6. PubMed ID: 1586878
[TBL] [Abstract][Full Text] [Related]
14. Effects of orally inhaled budesonide in seasonal allergic rhinitis.
Greiff L; Andersson M; Svensson C; Linden M; Wollmer P; Brattsand R; Persson CG
Eur Respir J; 1998 Jun; 11(6):1268-73. PubMed ID: 9657565
[TBL] [Abstract][Full Text] [Related]
15. Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment.
Greiff L; Petersen H; Mattsson E; Andersson M; Erjefält JS; Linden M; Svensson C; Persson CG
Clin Exp Allergy; 2001 Aug; 31(8):1321-7. PubMed ID: 11529904
[TBL] [Abstract][Full Text] [Related]
16. Immediate effect of topical budesonide on allergen challenge-induced nasal mucosal fluid levels of granulocyte-macrophage colony-stimulating factor and interleukin-5.
Linden M; Svensson C; Andersson E; Andersson M; Greiff L; Persson CG
Am J Respir Crit Care Med; 2000 Nov; 162(5):1705-8. PubMed ID: 11069800
[TBL] [Abstract][Full Text] [Related]
17. Effects of TNFalpha on the human nasal mucosa in vivo.
Widegren H; Korsgren M; Andersson M; Greiff L
Respir Med; 2007 Sep; 101(9):1982-7. PubMed ID: 17532197
[TBL] [Abstract][Full Text] [Related]
18. Effects of topical budesonide and levocabastine on nasal symptoms and plasma exudation responses in seasonal allergic rhinitis.
Svensson C; Andersson M; Greiff L; Blychert LO; Persson CG
Allergy; 1998 Apr; 53(4):367-74. PubMed ID: 9574878
[TBL] [Abstract][Full Text] [Related]
19. Allergen-induced mucosal exudation of plasma into rat ileum and its inhibition by budesonide.
Gustafsson B; Persson CG
Scand J Gastroenterol; 1992 Jul; 27(7):587-93. PubMed ID: 1641585
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of nasal barrier dysfunction at acute- and late-phase reactions in a guinea pig model of allergic rhinitis.
Elovsson S; Smailagic A; Erjefalt I; Zackrisson C; Eriksson C; Wang X
Vascul Pharmacol; 2005 Oct; 43(4):267-76. PubMed ID: 16257271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
